{"transactions":[{"id":677351,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-08-24T21:00:26.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.97,"value":7940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4, filed on June 12, 2026, inadvertently used transaction code 'A' instead of transaction code 'P'. This amendment corrects the transaction code."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":152927,"source":{"system":"sec-edgar","filing":"0001193125-26-363747","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526363747/ownership.xml","form_type":"4/A","original_submission_date":"2026-06-12"}},{"id":739762,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-06-12T20:30:05.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":3.97,"value":7940.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":152927,"source":{"system":"sec-edgar","filing":"0001193125-26-269544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526269544/ownership.xml","form_type":"4"}},{"id":756977,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-06-01T20:39:06.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":3.0515,"value":15257.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs"}],"balance_after":150927,"source":{"system":"sec-edgar","filing":"0001193125-26-251588","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526251588/ownership.xml","form_type":"4"}},{"id":769954,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-20T20:30:06.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.26,"value":8520.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":145927,"source":{"system":"sec-edgar","filing":"0001193125-26-232686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526232686/ownership.xml","form_type":"4"}},{"id":771978,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-19T20:30:02.000Z","date":"2026-05-19","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.24,"value":8480.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":143927,"source":{"system":"sec-edgar","filing":"0001193125-26-230874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526230874/ownership.xml","form_type":"4"}},{"id":848631,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-11T20:30:07.000Z","date":"2026-03-11","kind":"purchase","planned":false,"acquired":true,"shares":1800,"price":4.78,"value":8604.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs"}],"balance_after":141927,"source":{"system":"sec-edgar","filing":"0001193125-26-102263","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526102263/ownership.xml","form_type":"4"}},{"id":888063,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-23T21:30:08.000Z","date":"2026-02-19","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":4.15,"value":12450.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes unvested RSUs."}],"balance_after":140127,"source":{"system":"sec-edgar","filing":"0001193125-26-064111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526064111/ownership.xml","form_type":"4"}},{"id":893291,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-02-19T21:38:20.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":155510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026."}],"balance_after":155510,"derivative":{"exercise_price":4.31,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":155510},"source":{"system":"sec-edgar","filing":"0001193125-26-059552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526059552/ownership.xml","form_type":"4"}},{"id":893290,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-19T21:38:20.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":105470,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of restricted stock units (the \"RSUs\"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the \"Common Stock\"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":137127,"source":{"system":"sec-edgar","filing":"0001193125-26-059552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000119312526059552/ownership.xml","form_type":"4"}},{"id":1055613,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-08-26T20:30:23.000Z","date":"2025-08-26","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.52,"value":9040.0,"ownership":{"direct":true},"balance_after":31657,"source":{"system":"sec-edgar","filing":"0000950170-25-111467","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025111467/ownership.xml","form_type":"4"}},{"id":1068833,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-08-12T20:30:15.000Z","date":"2025-08-12","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.81,"value":9620.0,"ownership":{"direct":true},"balance_after":29657,"source":{"system":"sec-edgar","filing":"0000950170-25-107387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025107387/ownership.xml","form_type":"4"}},{"id":1127600,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-06-02T20:30:06.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":1923,"price":4.777,"value":9186.171,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2024 and ended on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2024 and ended on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 30, 2025 (the purchase date of the offering period)."}],"balance_after":27657,"source":{"system":"sec-edgar","filing":"0000950170-25-080304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025080304/ownership.xml","form_type":"4"}},{"id":1255655,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-20T21:30:08.000Z","date":"2025-02-20","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":9.9,"value":9900.0,"ownership":{"direct":true},"balance_after":25734,"source":{"system":"sec-edgar","filing":"0000950170-25-024204","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025024204/ownership.xml","form_type":"4"}},{"id":1259813,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-02-19T21:30:04.000Z","date":"2025-02-19","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":10.25,"value":10250.0,"ownership":{"direct":true},"balance_after":24734,"source":{"system":"sec-edgar","filing":"0000950170-25-023233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025023233/ownership.xml","form_type":"4"}},{"id":1297498,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-01-22T21:30:05.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date."}],"balance_after":150000,"derivative":{"exercise_price":8.73,"expiration_date":"2034-01-21","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-007794","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017025007794/ownership.xml","form_type":"4"}},{"id":1341544,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-12-05T22:00:07.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":12.4,"value":6200.0,"ownership":{"direct":true},"balance_after":23734,"source":{"system":"sec-edgar","filing":"0000950170-24-133748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024133748/ownership.xml","form_type":"4"}},{"id":1341543,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-12-05T22:00:07.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":475,"price":12.53,"value":5951.75,"ownership":{"direct":true},"balance_after":23234,"source":{"system":"sec-edgar","filing":"0000950170-24-133748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024133748/ownership.xml","form_type":"4"}},{"id":1341542,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-12-05T22:00:07.000Z","date":"2024-11-29","kind":"grant","planned":false,"acquired":true,"shares":785,"price":7.83,"value":6146.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period which began on June 1, 2024 and which ended on November 30, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 3, 2024 (the purchase date of the offering period)."}],"balance_after":22759,"source":{"system":"sec-edgar","filing":"0000950170-24-133748","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024133748/ownership.xml","form_type":"4"}},{"id":1495071,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-03T20:27:02.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":2240,"price":8.1685,"value":18297.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 31, 2024 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on May 31, 2024 (the purchase date of the offering period)."}],"balance_after":21974,"source":{"system":"sec-edgar","filing":"0000950170-24-068006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024068006/ownership.xml","form_type":"4"}},{"id":1495070,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-03T20:27:02.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":8.6,"value":4300.0,"ownership":{"direct":true},"balance_after":19734,"source":{"system":"sec-edgar","filing":"0000950170-24-068006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024068006/ownership.xml","form_type":"4"}},{"id":1495069,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-06-03T20:27:02.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":9.2,"value":4600.0,"ownership":{"direct":true},"balance_after":19234,"source":{"system":"sec-edgar","filing":"0000950170-24-068006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024068006/ownership.xml","form_type":"4"}},{"id":1612247,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-28T21:04:52.000Z","date":"2024-02-28","kind":"purchase","planned":false,"acquired":true,"shares":250,"price":17.43,"value":4357.5,"ownership":{"direct":true},"balance_after":18734,"source":{"system":"sec-edgar","filing":"0000950170-24-022050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024022050/ownership.xml","form_type":"4"}},{"id":1612246,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-02-28T21:04:52.000Z","date":"2024-02-28","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.38,"value":17380.0,"ownership":{"direct":true},"balance_after":18484,"source":{"system":"sec-edgar","filing":"0000950170-24-022050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024022050/ownership.xml","form_type":"4"}},{"id":1685448,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-01-05T22:49:33.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options vest in three equal annual installments beginning with the first anniversary of the grant date."}],"balance_after":125000,"derivative":{"exercise_price":12.64,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-002565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017024002565/ownership.xml","form_type":"4"}},{"id":1714224,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-12-12T21:37:38.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":950,"price":12.45,"value":11827.5,"ownership":{"direct":true},"balance_after":17484,"source":{"system":"sec-edgar","filing":"0000950170-23-069750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023069750/ownership.xml","form_type":"4"}},{"id":1723769,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-12-05T00:06:26.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":10.68,"value":5340.0,"ownership":{"direct":true},"balance_after":16534,"source":{"system":"sec-edgar","filing":"0000950170-23-067875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023067875/ownership.xml","form_type":"4"}},{"id":1723768,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-12-05T00:06:26.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":1034,"price":9.061,"value":9369.074,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on July 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on July 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Company's stock on November 30, 2023 (the purchase date of the offering period)."}],"balance_after":16034,"source":{"system":"sec-edgar","filing":"0000950170-23-067875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023067875/ownership.xml","form_type":"4"}},{"id":1732571,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-21T21:15:15.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":10.26,"value":10260.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000950170-23-065502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023065502/ownership.xml","form_type":"4"}},{"id":1732570,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-21T21:15:15.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":10.3,"value":10300.0,"ownership":{"direct":true},"balance_after":14000,"source":{"system":"sec-edgar","filing":"0000950170-23-065502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023065502/ownership.xml","form_type":"4"}},{"id":1738985,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-16T19:38:24.000Z","date":"2023-11-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":12.45,"value":12450.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0000950170-23-064444","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023064444/ownership.xml","form_type":"4"}},{"id":1738984,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-16T19:38:24.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":12.15,"value":12150.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000950170-23-064444","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023064444/ownership.xml","form_type":"4"}},{"id":1740635,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-15T21:31:51.000Z","date":"2023-11-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":13.25,"value":13250.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0000950170-23-064208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023064208/ownership.xml","form_type":"4"}},{"id":1740634,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-11-15T21:31:51.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":12.88,"value":12880.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-23-064208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023064208/ownership.xml","form_type":"4"}},{"id":1805746,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-08-16T21:57:10.000Z","date":"2023-08-16","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.06,"value":17060.0,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0000950170-23-043056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023043056/ownership.xml","form_type":"4"}},{"id":1805745,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-08-16T21:57:10.000Z","date":"2023-08-16","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.05,"value":17050.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0000950170-23-043056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023043056/ownership.xml","form_type":"4"}},{"id":1807310,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-08-15T20:43:09.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.93,"value":17930.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000950170-23-042840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023042840/ownership.xml","form_type":"4"}},{"id":1807309,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-08-15T20:43:09.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.94,"value":17940.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000950170-23-042840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023042840/ownership.xml","form_type":"4"}},{"id":1807308,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-08-15T20:43:09.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.96,"value":17960.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000950170-23-042840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023042840/ownership.xml","form_type":"4"}},{"id":1807307,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-08-15T20:43:09.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.89,"value":17890.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0000950170-23-042840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023042840/ownership.xml","form_type":"4"}},{"id":1807306,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-08-15T20:43:09.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":17.92,"value":17920.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000950170-23-042840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000095017023042840/ownership.xml","form_type":"4"}},{"id":1847787,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-06-21T22:50:27.000Z","date":"2023-06-20","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":16.15,"value":16150.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-23-038909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000120919123038909/doc4.xml","form_type":"4"}},{"id":1852137,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-16T20:25:51.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date."}],"balance_after":150000,"derivative":{"exercise_price":17,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-037870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000120919123037870/doc4.xml","form_type":"4"}},{"id":1973307,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T13:57:07.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":10750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":12.15,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":10750},"source":{"system":"sec-edgar","filing":"0001385508-23-000053","document":"wf-form4_167785181398452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000053/wf-form4_167785181398452.xml","form_type":"4"}},{"id":1973306,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T13:57:07.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":13.6,"exercise_date":"2020-02-07","expiration_date":"2030-01-07","underlying":"Common Stock","underlying_shares":8250},"source":{"system":"sec-edgar","filing":"0001385508-23-000053","document":"wf-form4_167785181398452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000053/wf-form4_167785181398452.xml","form_type":"4"}},{"id":1973305,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T13:57:07.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":13.61,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001385508-23-000053","document":"wf-form4_167785181398452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000053/wf-form4_167785181398452.xml","form_type":"4"}},{"id":1973304,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T13:57:07.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":20,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Disposed of pursuant the Merger Agreement, in exchange for the Merger Consideration. The number of shares disposed of reflects 2,000 shares of Common Stock upon the acceleration of vesting of performance stock units in accordance with the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001385508-23-000053","document":"wf-form4_167785181398452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000053/wf-form4_167785181398452.xml","form_type":"4"}},{"id":1973303,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T13:57:07.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"2,000 shares are represented by performance stock units (\"PSUs\"), the vesting of which accelerated in accordance with the Merger Agreement. Each PSU represents the Reporting Person's right to receive one share of Common Stock of Issuer."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001385508-23-000053","document":"wf-form4_167785181398452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000053/wf-form4_167785181398452.xml","form_type":"4"}},{"id":1973302,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T13:57:07.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":11736,"price":20,"value":234720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration. The number of shares disposed of reflects 11,736 shares of Common Stock upon the acceleration of vesting of restricted stock units in accordance with the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001385508-23-000053","document":"wf-form4_167785181398452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000053/wf-form4_167785181398452.xml","form_type":"4"}},{"id":1973301,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T13:57:07.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":22512,"price":20,"value":450240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Indivior Inc., and Olive Acquisition Subsidiary, Inc., dated as of November 13, 2022 (the \"Merger Agreement\"), in exchange for a cash payment of $20.00 per share without interest thereon (the \"Merger Consideration\")."}],"balance_after":11736,"source":{"system":"sec-edgar","filing":"0001385508-23-000053","document":"wf-form4_167785181398452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000053/wf-form4_167785181398452.xml","form_type":"4"}},{"id":2040266,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-31T21:17:29.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":541,"price":20.26,"value":10960.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":34248,"source":{"system":"sec-edgar","filing":"0001385508-23-000030","document":"wf-form4_167519983426592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000030/wf-form4_167519983426592.xml","form_type":"4"}},{"id":2058796,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-09T22:16:08.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":415,"price":20.2,"value":8383.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":34789,"source":{"system":"sec-edgar","filing":"0001385508-23-000024","document":"wf-form4_167330254788792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000024/wf-form4_167330254788792.xml","form_type":"4"}},{"id":2062528,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-05T22:03:45.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":1600,"price":20.2,"value":32320.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":35204,"source":{"system":"sec-edgar","filing":"0001385508-23-000011","document":"wf-form4_167295619781599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550823000011/wf-form4_167295619781599.xml","form_type":"4"}},{"id":2206975,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-15T20:06:56.000Z","date":"2022-07-14","kind":"sale","acquired":false,"shares":779,"price":11.1,"value":8646.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of performance stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.82 to $11.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":36804,"source":{"system":"sec-edgar","filing":"0001385508-22-000112","document":"wf-form4_165791560118442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550822000112/wf-form4_165791560118442.xml","form_type":"4"}},{"id":2219359,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-29T20:04:53.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the acquisition of shares upon the determination on June 27, 2020 by the Compensation and Human Capital Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to a portion of the performance stock units granted to the Reporting Person on January 4, 2022."}],"balance_after":37583,"source":{"system":"sec-edgar","filing":"0001385508-22-000102","document":"wf-form4_165653307620662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550822000102/wf-form4_165653307620662.xml","form_type":"4"}},{"id":2436808,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-12T21:39:03.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":432,"price":30.6,"value":13219.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $29.03 to $30.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":35583,"source":{"system":"sec-edgar","filing":"0001385508-22-000022","document":"wf-form4_164202352936884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550822000022/wf-form4_164202352936884.xml","form_type":"4"}},{"id":2443853,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-05T21:21:26.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"12,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-third of the RSUs vest on the anniversary dates of January 4, 2023, January 4, 2024 and January 4, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":36015,"source":{"system":"sec-edgar","filing":"0001385508-22-000012","document":"wf-form4_164141760647083.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550822000012/wf-form4_164141760647083.xml","form_type":"4"}},{"id":2569314,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-15T20:02:58.000Z","date":"2021-09-14","kind":"purchase","acquired":true,"shares":21,"price":19.05,"value":400.05,"ownership":{"direct":true},"balance_after":24015,"source":{"system":"sec-edgar","filing":"0001385508-21-000132","document":"wf-form4_163173616376901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550821000132/wf-form4_163173616376901.xml","form_type":"4"}},{"id":2569313,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-15T20:02:58.000Z","date":"2021-09-14","kind":"purchase","acquired":true,"shares":179,"price":19.13,"value":3424.27,"ownership":{"direct":true},"balance_after":23994,"source":{"system":"sec-edgar","filing":"0001385508-21-000132","document":"wf-form4_163173616376901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550821000132/wf-form4_163173616376901.xml","form_type":"4"}},{"id":2602255,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-08-16T20:47:36.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":600,"price":15.38,"value":9228.0,"ownership":{"direct":true},"balance_after":23815,"source":{"system":"sec-edgar","filing":"0001385508-21-000111","document":"wf-form4_162914682979973.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550821000111/wf-form4_162914682979973.xml","form_type":"4"}},{"id":2893459,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-27T21:20:07.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":10750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 26, 2021, the reporting person was granted an option to purchase 10,750 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of January 26, 2021, the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth year anniversary of the vesting commencement date."}],"balance_after":10750,"derivative":{"exercise_price":12.15,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":10750},"source":{"system":"sec-edgar","filing":"0001385508-21-000017","document":"wf-form4_161178239296219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550821000017/wf-form4_161178239296219.xml","form_type":"4"}},{"id":2893458,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-27T21:20:07.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":5400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"5,400 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of January 26, 2022, January 26, 2023, January 26, 2024 and January 26, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":23215,"source":{"system":"sec-edgar","filing":"0001385508-21-000017","document":"wf-form4_161178239296219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550821000017/wf-form4_161178239296219.xml","form_type":"4"}},{"id":2893457,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-27T21:20:07.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":2450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,450 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. 100% of the RSUs vest on the anniversary date of January 26, 2022, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":17815,"source":{"system":"sec-edgar","filing":"0001385508-21-000017","document":"wf-form4_161178239296219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550821000017/wf-form4_161178239296219.xml","form_type":"4"}},{"id":3113351,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-11T20:06:25.000Z","date":"2020-06-11","kind":"purchase","acquired":true,"shares":1000,"price":8.74,"value":8740.0,"ownership":{"direct":true},"balance_after":15365,"source":{"system":"sec-edgar","filing":"0001385508-20-000067","document":"wf-form4_159190596595509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550820000067/wf-form4_159190596595509.xml","form_type":"4"}},{"id":3135189,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-26T20:25:52.000Z","date":"2020-05-26","kind":"purchase","acquired":true,"shares":1000,"price":11,"value":11000.0,"ownership":{"direct":true},"balance_after":14365,"source":{"system":"sec-edgar","filing":"0001385508-20-000061","document":"wf-form4_159052473424099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550820000061/wf-form4_159052473424099.xml","form_type":"4"}},{"id":3314492,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-09T21:14:30.000Z","date":"2020-01-07","kind":"grant","acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 7, 2020, the reporting person was granted an option to purchase 8,250 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth year anniversary of the Grant Date."}],"balance_after":8250,"derivative":{"exercise_price":13.6,"exercise_date":"2020-02-07","expiration_date":"2030-01-07","underlying":"Common Stock","underlying_shares":8250},"source":{"system":"sec-edgar","filing":"0001385508-20-000017","document":"wf-form4_157860445295848.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550820000017/wf-form4_157860445295848.xml","form_type":"4"}},{"id":3314491,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-09T21:14:30.000Z","date":"2020-01-07","kind":"grant","acquired":true,"shares":4150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"4,150 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of January 7, 2021, January 7, 2022, January 7, 2023 and January 7, 2024, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":13365,"source":{"system":"sec-edgar","filing":"0001385508-20-000017","document":"wf-form4_157860445295848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550820000017/wf-form4_157860445295848.xml","form_type":"4"}},{"id":3358757,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-26T21:01:29.000Z","date":"2019-11-26","kind":"purchase","acquired":true,"shares":100,"price":13.22,"value":1322.0,"ownership":{"direct":true},"balance_after":9215,"source":{"system":"sec-edgar","filing":"0001385508-19-000121","document":"wf-form4_157480207097959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550819000121/wf-form4_157480207097959.xml","form_type":"4"}},{"id":3369855,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-15T21:02:18.000Z","date":"2019-11-15","kind":"purchase","acquired":true,"shares":100,"price":15,"value":1500.0,"ownership":{"direct":true},"balance_after":9115,"source":{"system":"sec-edgar","filing":"0001385508-19-000117","document":"wf-form4_157385172311589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550819000117/wf-form4_157385172311589.xml","form_type":"4"}},{"id":3369854,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-15T21:02:18.000Z","date":"2019-11-15","kind":"purchase","acquired":true,"shares":1000,"price":14.91,"value":14910.0,"ownership":{"direct":true},"balance_after":9015,"source":{"system":"sec-edgar","filing":"0001385508-19-000117","document":"wf-form4_157385172311589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550819000117/wf-form4_157385172311589.xml","form_type":"4"}},{"id":3437562,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-15T20:05:31.000Z","date":"2019-08-15","kind":"purchase","acquired":true,"shares":1000,"price":15.2,"value":15200.0,"ownership":{"direct":true},"balance_after":8015,"source":{"system":"sec-edgar","filing":"0001385508-19-000088","document":"wf-form4_156589951599581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550819000088/wf-form4_156589951599581.xml","form_type":"4"}},{"id":3439923,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-13T20:02:46.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":1000,"price":15.46,"value":15460.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $15.40 to $15.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":7015,"source":{"system":"sec-edgar","filing":"0001385508-19-000086","document":"wf-form4_156572654992515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550819000086/wf-form4_156572654992515.xml","form_type":"4"}},{"id":3704015,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-04T22:18:18.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 3, 2019, the reporting person was granted an option to purchase 33,000 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth anniversary of the Grant Date."}],"balance_after":33000,"derivative":{"exercise_price":13.61,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001385508-19-000006","document":"wf-form4_154664028137802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550819000006/wf-form4_154664028137802.xml","form_type":"4"}},{"id":3844748,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-14T20:04:52.000Z","date":"2018-08-14","kind":"purchase","acquired":true,"shares":1000,"price":15.39,"value":15390.0,"ownership":{"direct":true},"balance_after":6015,"source":{"system":"sec-edgar","filing":"0001385508-18-000071","document":"wf-form4_153427698317213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550818000071/wf-form4_153427698317213.xml","form_type":"4"}},{"id":3844747,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-14T20:04:52.000Z","date":"2018-08-14","kind":"purchase","acquired":true,"shares":15,"price":16.4,"value":246.0,"ownership":{"direct":true},"balance_after":5015,"source":{"system":"sec-edgar","filing":"0001385508-18-000071","document":"wf-form4_153427698317213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550818000071/wf-form4_153427698317213.xml","form_type":"4"}},{"id":3930838,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-16T20:01:51.000Z","date":"2018-05-16","kind":"purchase","acquired":true,"shares":2000,"price":16.95,"value":33900.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001385508-18-000045","document":"wf-form4_152650089733388.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550818000045/wf-form4_152650089733388.xml","form_type":"4"}},{"id":3934748,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-14T20:01:12.000Z","date":"2018-05-11","kind":"purchase","acquired":true,"shares":3000,"price":18.85,"value":56550.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001385508-18-000041","document":"wf-form4_152632805284065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550818000041/wf-form4_152632805284065.xml","form_type":"4"}},{"id":4104223,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-08T23:34:24.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":13200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 4, 2018, the reporting person was granted an option to purchase 13,200 shares of common stock. The option vests as follows: Twenty-five percent (25%) of the shares of common stock underlying the option shall vest on the one-year anniversary of the date of grant, and 2.083% of the shares of common stock underlying the option shall vest monthly thereafter, becoming fully vested on the four-year anniversary of the date of grant."}],"balance_after":13200,"derivative":{"exercise_price":24.84,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0001385508-18-000004","document":"wf-form4_151545445086053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000138550818000004/wf-form4_151545445086053.xml","form_type":"4"}},{"id":4209369,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-14T23:00:37.000Z","date":"2017-09-12","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 12, 2017, the reporting person was granted an option to purchase 150,000 shares of common stock. The option vests as follows: Twenty-five percent (25%) of the shares of common stock underlying the option shall vest on the one-year anniversary of the date of grant, and 2.083% of the shares of common stock underlying the option shall vest monthly thereafter, becoming fully vested on the four-year anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On September 12, 2017, the reporting person was granted an option to purchase 150,000 shares of common stock. The option vests as follows: Twenty-five percent (25%) of the shares of common stock underlying the option shall vest on the one-year anniversary of the date of grant, and 2.083% of the shares of common stock underlying the option shall vest monthly thereafter, becoming fully vested on the four-year anniversary of the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":36,"exercise_date":"2018-09-12","expiration_date":"2027-09-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001144204-17-048089","document":"v475189_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000114420417048089/v475189_4.xml","form_type":"4"}},{"id":4346641,"issuer":{"id":46432,"kind":"organization","name":"SOLENO THERAPEUTICS INC","symbol":"SLNO"},"owners":[{"id":20338,"kind":"person","name":"O'Toole David D","position":1,"cik":"0001491140","reported_name":"O'Toole David D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2017-04-24T10:17:25.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":354945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4) of the shares subject to the Option shall vest immediately on the Vesting Commencement Date (which is April 19, 2017), and one forty-eighth (1/48) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to Participant continuing to be a Service Provider through each such date."}],"balance_after":354945,"derivative":{"exercise_price":0.59,"expiration_date":"2027-04-19","underlying":"Common Stock","underlying_shares":354945},"source":{"system":"sec-edgar","filing":"0000899243-17-010763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1491140/000089924317010763/doc4.xml","form_type":"4"}}]}